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THERE have been many attempts to devise prognostic tests for deciding which
patients suffering from breast cancer would benefit from such treatments as
hormone therapy or ablation of endocrine glands. Most of these attempts have
depended on the measurements of substances in blood or urine (Bulbrook, 1965),
but an alternative and complementary approach might be to carry out some
biochemical analyses of the tumour itself. Much of the previous work has been
concerned with individual enzymes but a simultaneous study of a number of
biochemical variables in the same tissue may be ofgreater interest, since differences
in the biochemical patterns of different tissues may be more readily revealed in
this way. This approach has been used advantageously with animal tissues
(Rees and Huggins, 1960; Reid, 1964; Shonk, Morris and Boxer, 1965) and
recently it has been applied to some human carcinomata (Shonk, Arison, Koven,
Majima and Boxer, 1965). Most of our knowledge ofthe biochemistry oftumours
has been obtained from experimental animals rather than humans and even with
animals, comparatively little attention has been given to the biochemistry of
breast neoplasms. Rees and Huggins (1960) studied a number of dehydrogenases
in experimentally induced rat mammary carcinomata and reported differences
between hormone-responsive and unresponsive tumours. Results from this
laboratory have shown differences in steroid metabolism in hormone responsive
and unresponsive rat and mouse mammary tumours (King, Panatonni, Gordon
and Baker, 1965; Smith and King, 1966). These findings encourage the
hope that similar differences may be found among human breast carcinomata.
Preliminary studies indicated that the in vitro metabolism of testosterone by
human mammary carcinomata was very small so attention was confined to more
readily measurable enzymes. This paper reports a preliminary study of a number
of variables in malignant and non-malignant human breast tissues.
MATERIALS AND METHODS
Human tissues
Tissue samples were obtained within ten minutes of excision. All the malig-
nant tumours were primary breast carcinomata (Stage I or II). Non-malignant
tissue was obtained either from the sub-areolar part of cancer bearing breasts,
or as tissue removed from patients with cystic glandular hyperplasia. Tissues
were frozen on solid carbon dioxide and stored at 20°C. until used. This does
not affect the enzyme activities significantly (Shonk and Boxer, 1964).336 J. A. SMITH, R. J. B. KING, B. F. MEGGITT AND L. N. ALLEN
Rat tissue
Mammary tumours were induced by feeding dimethylbenzanthracene (DMBA)
to female Sprague-Dawley rats (Young, Cowan and Sutherland, 1963). Tumour
size was measured twice a week. Some ofthe tumours were taken while growing;
the others had stopped growing at least two weeks before they were used. (These
tumours were used only for measurement of acidic nuclear protein content).
Assay Methods
The assays were performed in three stages, each requiring one homogenization.
1. DNA, RNA, total protein, phosphohexose isomerase (PHI) and 3-glucuronidase
Slices (200 mg.) were cut from the frozen tissue and homogenized with a
Silverson homogenizer (Silverson Ltd., London) in 1*8 ml. of a solution containing
KCI (0.15 M), NaHCO3 (0.003 M) and ethylenediamine tetraacetate (EDTA;
0.006 M pH 6-7).
DNA and RNA.-Normal perchloric acid (HCl04) (1 ml.) was added to 1 ml.
of the homogenate and the precipitate washed twice with 2 ml. of 0 5 N HC104,
and then heated at 70°C. for fifteen minutes in 2*5 ml. of 0-5 N HC104. The
remaining solids were centrifuged and discarded.
Duplicate 0*5 ml. samples were used for DNA estimation by the method of
Burton (1956) and two 0-5 ml. samples were used for RNA estimations according
to Greenbaum and Slater (1957).
Totalprotein.-This was measured in 0 1 ml. ofthe homogenate by the method
of Lowry, Rosebrough, Farr and Randall (1951).
Phosphohexose isomerase (PHI).-The homogenate (0.1 ml.) was diluted to
1 ml. with water: 0-2-0*5 ml. of this was incubated for ten minutes at 370C. in
2 ml. of an aqueous solution containing tris buffer (0.025 M, pH 7-4) and 0-2 ml.
of 0-1 M glucose-6-phosphate. The reaction was stopped by adding 2 ml. of
5% w./v. trichloroacetic acid (TCA) and the fructose-6-phosphate determined
(Bodansky, 1954).
/3-glucuronidase.-The method was taken from the Sigma Chemical Co. (St.
Louis, U.S.A.) Bulletin 105 (1951). For each tissue two incubation flasks were
set up, both containing 0 5 ml. of homogenate and one containing 0-1 ml. of
0-01% Triton X-100 to release any bound enzyme.
2. Lactate dehydrogenase (LD), NADP-specific isocitrate dehydrogenase (ICD),
qlucose-6-phosphate dehydrogenase (G6PD) and 6-phosphogluconate dehydro-
genase (6PGD)
A second homogenate was prepared, as above, and centrifuged at 2000 g
for thirty minutes at 4°C. The supernatant was kept on ice until used.
The enzyme activities were measured by recording the rates of change in
absorbance at 340m/t due to the oxidation or reduction of the appropriate
nicotinamide adenine dinucleotide, using a Unicam SP700 recording spectrophoto-
meter. The conditions were chosen to give maximal rates at pH 7-4. In nearly
all cases the rate curves were zero order for at least three minutes; even the
most active preparations used were always zero order over the first minute.
In general; the cuvettes were made up with all the components except enzyme
substrate, and the optical density recorded for about thirty seconds to measureENZYMES IN BREAST TISSUES
anv endogenous oxidation or reduction. The substrate was then added in 0-1 ml.
of water, mixed rapidly with a microspatula, and the recording continued for
another two to three minutes.
All cuvettes contained 0.1 ml. of 0-6 M nicotinamide and 1-0 ml. of 0.2 M tris
buffer, pH 7-4. The final volume in all cases was 3 ml.
Lactate dehydrogenase.-The cuvette was made up with 0.1 ml. of 4 0 mm
NADH and 0 05-0 2 ml. of tissue extract. The reaction was initiated by addition
of 0.1 ml. of 0.033 M sodium pyruvate.
N\AADP specific isocitrate dehydrogenase. The cuvette was made up with
0.1 ml. of 0.014 m NADP, 0.1 ml. of0.01 M MnC]2 and 0.2-0.5 ml. of tissue extract.
The reaction was initiated with 0*1 ml. of 0-06 M sodium isocitrate.
Glucose 6-phosphate dehydrogenase.-The cuvette was made with 0-1 ml. of
0-014 M NADP, 0-1 ml. of 0-3 M MgCI2 and 0-2-1-0 mnl. of tissue extract. The
reaction was initiated with 0-1 ml. of 0.1 M glucose-6-phosphate. No correction
has been applied for 6-phosphogluconate dehydrogenase activity when measuring
glucose-6-phosphate dehydrogenase activity. Under our conditions the amount
of 6-phosphogluconate produced by the end of 3 minutes has not exceeded 0 5 ,a
moles; with this amount of substrate, 6-phosphogluconate activity is about 10%
of its maximum in our system. From this we conclude that the excess G6PD
activity from this cause can seldom exceed 500 (6PGD activity being about
half that of G6PD).
6-phosphogluconate dehydrogenase.- The cuvette was prepared as for glucose-6-
phosphate dehydrogenase and the reaction initiated by addition of 0.1 ml. of
0.1 M 6-phosphogluconate.
3. Acidic nuclear protein
Frozen tissue (100-200 mg.) was homogenized in 3 ml. of cold 0-25 M sucrose:
3 mmt CaC12 and filtered through a wire gauze. Nuclei were isolated by the
method of Allfrey, Littau and Mirsky (1964). The nuclei were examined micro-
scopically to ensure that they were substantially free ofcytoplasm, then suspended
in 2 ml. of0.01 M tris: 3 mm CaC12, and left at 0°C. for five minutes. The suspension
was centrifuged at 1000 g for 10 minutes at 40 C. and the extraction was repeated
on the sediment. This removes soluble proteins and nuclear ribosomes (Frenster,
Allfrey and Mirsky, 1960). The pellet was suspended in 5 ml. of 0.2 N HC1, left
for 5 minutes at 0 C., centrifuged for 10 minutes to remove basic proteins, and the
sediment shaken with 1 ml. of 0-5 N PCA. This suspension was heated at 70°C.
for 15 minutes and centrifuged. DNA was estimated in the supernatant (Burton,
1956) and the precipitate treated with 1 N NaOH for 30 minutes for the protein
determination (Lowry et al., 1951).
Units
Enzyme activities were expressed in International Units (U) ; one unit is
the amount of enzyme that will transform one It mole of substrate in one minute
under stated conditions.
RESULTS
All the results could be duplicated with good agreement in different homo-
genates of the same tissue, either made concurrently or over a period of several
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weeks, but in general all measurements were completed within two weeks of
collecting the tissue.
In general DNA, RNA, total protein and the enzymes were lower in the non-
malignant tissues than in the carcinomata when expressed per g. wet weight.
The differences were partly due to the greater cellularity of the malignant tissues,
which was reflected in their DNA concentration; the mean DNA content per g.
wet weight was 2-73 mg. for malignant tissue and 0-88 mg. for non-malignant
breast tissues. For this reason comparison of these tissues on a wet weight
basis is of limited value. In an attempt to allow for differences in cellularity,
the results have been calculated per mg. DNA, and also per 100 mg. total protein.
TABLE I.-Comparison of Malignant and Non-malignant Human
Breast Tissues
Malignant tissue
Stand-
Number ard
of devia-
estima- tion
Variable Mean tions (+)
A. (Values calculated per mg. DNA)
Total protein (mg.) . . 62-7 17 52-5
Acidic nuclear protein (mg.) . 2-55 14 1- 15
RNA (mg.) * * . 1-44 16 0-51
Lactate dehydrogenase (U) . 10-0 17 3-3
Glucose-6-phosphate dehydro- 0-58 16 0-29
genase (U)
6-phosphogluconate dehydro- 0-26 15 0-15
genase (U)
Phosphohexose isomerase (U) 13-8 14 9-35
Free ,B-glucuronidase (U) 0-042 17 0-043
Total fl-glucuronidase (U) . 0-063 13 0-053
I8ocitrate dehydrogenase (U) 0-55 17 0-42
Non-malignant tissue
Stand-
Number ard
of devia-
estima- tion
Mean tions (±)
119-0
3-12
2-02
6-5
0-37
19
11
18
17
15
67-4
1-54
0-86
3-3
0-35
0-13 15 0-11 . <0-02
12-4
0-057
0-084
f042 (1)
l0- 15 (2)
17
19
15
10
7
7-1
0-033
0-041
0-39
0-09
B. (Values calculated per 100 mg. protein)
DNA (mg.) * * . 2-14 17 1-06
RNA(mg.) . . 2-9 16 0-11
Lactate dehydrogenase (U) . 21-4 17 12-5
Glucose-6-phosphate dehydro- 1-16 16 0-58
genase (U)
6-phosphogluconate dehydro- 0-47 15 0-38
genase (U)
Phosphohexose isomerase (U) 26-6 14 15-7
Free fl-glucuronidase (U) . 0-074 17 0-057
Total fl-glucuronidase (U) 0- 107 13 0-078
Isocitrate dehydrogenase (U) 1- 19 17 1-01
1-10 19 0-13 < 0-001
2-2 18 1-08 . <0-02
5-8 17 2-45 . <0-001
0-31 15 0-28 . <0-001
0-12 15 0-08 . <0-01
11-1
0-057
0-082
0-37
17
19
16
17
7-3
0-052
0-075
0-56
<0-01
>0-1
>0-1
<0-01
(1) Non-malignant tissue from patients with breast cancer fp 001.
(2) Tissue from patients without breast cancer
The data obtained are given in Table I. Sometimes, particularly in the
non-malignant tissues, ICD, G6PD and 6PGD activities were too low to measure.
In all calculations 0-07 UT/g. wet weight has been taken as the enzyme activity
whenever the true value could not be measured, as this was the smallest amount
of enzyme that could have been detected.
p
<0-01
>0-1
<0-05
<0-01
>0-1
>0-1
>0-1
>0-1
>0-1
<0-05
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Glyceraldehyde-3-phosphate dehydrogenase, although present in sufficient
amounts to be measured was found to be too unstable in homogenates to give
reliable results. This is in agreement with the findings of Shonk and Boxer
(1964).
a-Glycerol phosphate dehydrogenase and hexokinase, although sometimes
detectable, were not present in sufficient amounts to be measured using the
methods described by Shonk and Boxer (1964). We were also unable to detect
any nicotanamide adenine dinucleotide transhydrogenase, with or without added
oestradiol (Villee and Hagerman 1958).
Since it is possible that carcinomata affect their surrounding tissues. it was
necessary to see whether there was any difference between the mean values for
uninvolved tissue from carcinomatous breast and from breasts free of malignant
disease. Except for ICD activity/mg. DNA no differences were found, so the
data were pooled for comparison with the carcinomata. The ICD activity/mg.
DNA in uninvolved tissue from carcinomatous breasts was significantly higher
than in other non-malignant breast tissue, but not different from the activity in
carcinomata (Table IA). However, when calculated per 100 mg. protein, the
ICD activity was not different in the two types of non-malignant tissue, and in
both it was lower than in carcinomata; the pooled data have been used in Table
IB.
In general the results calculated per 100 mg. protein showed greater, aild
statistically more significant, differences between malignant and non-malignant
breast tissues than when DNA was used as standard. Thus, LD and 6PGD,
although significantly higher in carcinomata on either basis had a greater degree
of significance when referred to total protein; PHI and G6PD were significantly
higher in carcinomata on the protein basis, but not per mg. DNA, while RNA,
low per mg. DNA, was high per 100 mg. protein. There was no significant
difference in ,8-glucuronidase activity on either basis. In both tissues there was
usually more total ,8-glucuronidase than " free ", but no difference in the ratio of
" free " to total was found between the two tissues. There was also no significant
difference in the acidic nuclear protein content of malignant and non-malignant
breast tissues.
The two methods of expression are compared in Fig. 1, in which the mean
values for the carcinomata are shown as multiples of the means for non-malignant
breast tissues. Despite the quantitative differences between the two sets of
results mentioned above, both showed a similar qualitative pattern of changes in
which the carcinomata were characterized by relatively high dehydrogenase
activities, especially LD and ICD.
The variation in the individual values for any one parameter was very great,
and a more detailed analysis showed that much information was lost when the
results were presented as mean values. When the values for some parameters
were plotted against others in the same tumour, some interesting correlations
appeared. These are listed in Table II, and are discussed below. None of these
correlations could be detected in the non-malignant tissues.
A correlation has also been found between the ICD activities in the tumours
and in uninvolved breast tissue from the same patient (Fig. 2).
The acidic nuclear protein content ofgrowing rat mammary adenocarcinomata
was significantly higher than in the static tumours (Table III).
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TABLE II.-Correlated Variables in Malignant Human Breast Tisste
Number of Correlation
Variables estimations coefficient P
Phosphohexose isomerase:
Glucose-6-phosphate dehydrogenase . 14 . 0-8 . <0-001
Glucose-6-phosphate dehydrogenase:
Isocitrate dehydrogenase . . 16 0- 73 . <001
Phosphohexose isomerase:
Isocitrate dehydrogenase 14 . 0 4 . <0-05
Lactate dehydrogenase:
6-phosphogluconate dehydrogenase . 15 . 0-66 . <0-01
Acidic nuclear protein:
fl-glucuronidase . . . 13 . 0 90 . <0001
TABLE III.-Acidic Nluclear Protein C(ontent of DMBA Induced Rat
Mammnary Adenocarcinomata
Acidic
nuclear
protein
(mg./mg. Number of Standard
DNA) estimations deviation P
Growing tumours . 2-21 . 16 . 0-97 . <0-01
Static tumours . 1-31 . 9 . 039
DISCUSSION
The low protein content per mg. DNA in breast carcinoma agrees with previous
reports, based on cell counts, that neoplastic cells are deficient in protein (Weber
and Morris, 1963). The RNA: DNA ratio was low in breast carcinoma, as in
rat hepatoma (Novikoff, 1960).
The metabolic significance of the enzyme measurements is difficult to assess,
since they were all measured under nearly optimal conditions in vitro, and their
relative activities in vivo could be quite different. However, the differences
found between malignant and non-malignant tissues were consistent with the
view that neoplastic tissues are characterized by a high aerobic and anaerobic
glycolysis (Aisenberg, 1961). The elevated ratios of G6PD and 6PGD to PHI
in the tumours were compatible with an increased activity of the hexose mono-
phosphate shunt (Aisenberg, 1961).
Our results agree with the report ofFishman and Anlayan (1947) that /]-glucu-
ronidase activity per g. wet weight is higher in human breast carcinoma than in
normal breast tissue. However, the difference was not significant when the
results were expressed per mg. DNA or total protein. Odell and Burt (1949)
found high /-glucuronidase per g. wet weight in carcinoma of the cervix, but the
activity was related to the nitrogen content of the tissues. Although the " free
fl-glucuronidase was measured, the results were of doubtful value, as freezing and
thawing the tissue may have disrupted subcellular particles.
The correlations found between some of the variables in carcinomata are
surprising, considering that each activity represents the sum of a number of
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isoenzymes in a variety of cell types. These correlations cannot have been due
to systematic methodological errors, because in some cases the variables were
measured in different homogenates by different methods, and the results were
reproducible in different homogenates of the same tissue. Similarly the lack of
correlation between the other variables was not due simply to errors of measure-
ment, since all the enzymes appeared in at least one correlation. The variation
of any one parameter in different tumours might have been due to different
proportions of malignant cells in the populations sampled, but this is unlikely to
provide the full explanation; the proportion of malignant cells in breast tumours
probably varies between 20-80%. This, alone, could account for only a four
fold variation, assuming that non-malignant cells have no activity. Histochemical
evidence shows that stromal cells in these tumours are quite active (R. C. Hallowes,
personal communication) so it is unlikely that variation in cell proportions could
account for more than a 2-3 fold variation in enzyme activities. The actual
variations of 5-15 fold must have been mainly due to differences in activity of
the cells in the tumours, and it is noteworthy that variations have been observed
histochemically even among malignaint cells in the same sections of rat mammary
adenocarcinoma (R. C. Hallowes, personal communiaction).
The correlations indicate a very fine control of the biochemical pattern in
malignant breast tissue, even though the absolute amounts of any one enzyme
might vary considerably. It is known from the work of Pette and co-workers
(Pette, Luh and Bucher, 1962; Pette and Bucher, 1963) that some enzymes are
present in approximately constant proportions in different tissues. Our results
show that the same is true for different specimens of a single tissue, although
different groups of enzymes are involved. PHI and G6PD are correlated in
breast tumours, but do not form a constant proportion group among different
tissues (Shonk and Boxer, 1964). Conversely, G6PD and 6PGD are not correlated
in breast tumours although they occur in fairly constant proportions in different
tissues (Glock and McLean, 1954). The constant proportion groups of Pette
et al. were based on measurements with very large variations (1-2 hundredfold)
while our variables only differed over 5-15 fold ranges. These correlations
indicate a finer control of enzyme groups in breast tumours than that revealed
by Pette et al., and the explanation is probably different in each case.
The correlation between the acidic nuclear protein and ,-glucuronidase is of
particular interest. The early work of Stedman and Stedman (1944) and Mirsky
and Pollister (1946) showed that growing tissues contained more acidic nuclear
protein than non-growing tissues. The evidence reported here for rat mammary
tumours supports this idea. Recent work has indicated ways in which this
material could influence genetic control mechanisms (Butler, 1965 ; Frenster,
1965; Wang, 1965). Evidence has also been presented that 3-glucuronidase is
related to growth and oestrogen status (Levvy, 1953) of certain tissues. This
correlation might, therefore, provide some indication of the growth rate of these
tumours. It is also of interest that Whitaker (1961) has presented evidence that
Plasma /I-glucuronidase is higher in women with breast tumours that do not
respond to hypophysectomy than those with responsive tumours.
None of the correlations could be demonstrated in the non-malignant tissues.
This could indicate that the enzymic pattern in non-malignant breast is more
responsive to changes in physiological states than in malignant tissues. Such an
interpretation would be in agreement with work on rat hepatomas (Pitot, 1963).ENZYMES IN BREAST TISSUES 343
However, an alternative explanation could be found in the variability of the
pathology of " normal " breast.
The relationship between NADP specific ICD in tumours to that in apparently
uninvolved tissue from the same breast suggests that the tumour can influence, or
be influenced by the adjacent tissue. The fact that ICD activitv in these " nor-
mal " tissues is higher than in tissue from carcinoma-free breasts favours the
former view. This correlation is unlikely to be due to infiltration of the normal
tissue by malignant cells, as the other enzymes measured do not behave in the
same way, and the slope of the graph is very nearly 1.
The clinical significance of these results cannot be assessed at this time, but
the biochemical variability ofthese primary tumours of the breast is great enough
to encourage the hope that data of this kind may prove useful in the subsequent
clinical assessment of the disease.
SUMMARY
Phosphohexose isomerase, glucose-6-phosphate dehydrogenase, 6-phospho-
gluconate dehydrogenase, NADP-specific isocitrate dehydrogenase, lactate
dehydrogenase, ,-glucuronidase, DNA, RNA, total protein and acidic nuclear
protein have been measured in malignant and non-malignant human breast
tissues. The differences found between the two types of tissues were consistent
with the view that malignant tissues are characterized by increased glucose
metabolism, but the magnitude and statistical significance of the differences
depended on the standard of comparison used.
Some of the variables in breast carcinomata were found to be correlated.
These were: total ,-glucuronidase and acidic nuclear protein, phosphohexose
isomerase and glucose-6-phosphate dehydrogenase, glucose-6-phosphate dehydro-
genase and NADP specific isocitrate dehydrogenase, phosphohexose isomerase
and NADP specific isocitrate dehydrogenase, and lactate dehydrogenase and
6-phosphogluconate dehydrogenase. In a series of nine patients the isocitrate
dehydrogenase activity in malignant tissue was found to be correlated with the
activity in uninvolved tissue from the same breast.
Acid nuclear protein content was found to be significantly higher in growing
than in static dimethyl benzanthracene (DMBA)-induced rat mammary adeno-
carcinomata.
The authors wish to acknowledge the skilled assistance ofMr. F. E. H. Crawley.
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